Cite
HARVARD Citation
Schulze, K. et al. (n.d.). Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. International journal of cancer. 133 (9), pp. 2165-2171. [Online].